Onofrio Laselva

Foggia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Evaluation of ATP12A and NFKBIZ as potential markers of inflammatory status in cystic fibrosis airway epithelial cells.

Evaluation of ATP12A and NFKBIZ as potential markers of inflammatory status in cystic fibrosis airway epithelial cells.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: September 30, 2025

GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models.

GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: September 24, 2025

Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells.

Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells.

Journal: Biochemical pharmacology

Published: April 22, 2025

Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.

Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.

Journal: Journal of medicinal chemistry

Published: February 10, 2025

IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo.

IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo.

Journal: Cellular immunology

Published: October 31, 2024

Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived nasal cells.

Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived nasal cells.

Journal: ERJ open research

Published: September 23, 2024

Editorial: Mechanisms of action of small molecules on CFTR mutants and the impact on cystic fibrosis pathogenesis.

Editorial: Mechanisms of action of small molecules on CFTR mutants and the impact on cystic fibrosis pathogenesis.

Journal: Frontiers in molecular biosciences

Published: June 10, 2024

Testing organ-specific responses to therapies in tissues differentiated from Cystic Fibrosis patient derived iPSCs.

Testing organ-specific responses to therapies in tissues differentiated from Cystic Fibrosis patient derived iPSCs.

Journal: Stem cell research

Published: February 29, 2024

Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis.

Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis.

Journal: Cells

Published: May 06, 2023

IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression.

IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression.

Journal: International journal of molecular sciences

Published: January 28, 2023

The Oncogenic Theory of Preeclampsia: Is Amniotic Mesenchymal Stem Cells-Derived PLAC1 Involved?

The Oncogenic Theory of Preeclampsia: Is Amniotic Mesenchymal Stem Cells-Derived PLAC1 Involved?

Journal: International journal of molecular sciences

Published: January 09, 2023

Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium.

Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium.

Journal: Journal of personalized medicine

Published: August 22, 2022

Showing 1-12 of 53

Last Updated: 09/26/2026